Skip to main content

Table 4 Optimal lacosamide dosing regimens for critically ill patients receiving continuous renal replacement therapy with different effluent flow rates and modalities

From: Lacosamide dosing in patients receiving continuous renal replacement therapy

Effluent flow rates/modalities

Standard PD targets (Ctrough 5–10 mg/L or AUC 80.25–143 mg*h/L)

High PD targets (AUC 143–231 mg*h/L)

CVVHD

CVVH

CVVHD

CVVH

20 mL/kg/h

100–150 mg every 8 h

250 mg every 12 h OR 250 mg LD followed by 150 mg every 8 h

25 mL/kg/h

150 mg every 8 h

300 mg LD followed by 250 mg every 12 h

250 mg every 12 h OR 250 mg LD followed by 150 mg every 8 h

35 mL/kg/h

200 mg every 8 h

300 mg every 12 h

300 mg every 12 h OR

250 mg LD followed by 200 mg every 8 h

350 mg LD followed by 250 mg every 12 h

  1. PD pharmacodynamic, AUC area under the curve, CVVHD continuous venovenous hemodialysis, CVVH continuous venovenous hemofiltration